ArticleDiabetes, obesity & metabolism2026

Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach.

Alex E Henney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.